Lactobacillus johnsonii CCFM1376 improves hypercholesterolemia in mice by regulating the composition of bile acids

Abstract

Aim: Strains with high bile salt hydrolase (BSH) activity have the potential to regulate cholesterol metabolism. This study aimed to assess the alleviating effect of Lactobacillus johnsonii (L. johnsonii) CCFM1376, a strain with high BSH activity, on mice with hypercholesterolemia and explore the mechanism of its effect through the modulation of bile acid metabolism.

Methods: The BSH activity was measured using the ninhydrin method. C57BL/6J mice were given a high-cholesterol diet to induce hypercholesterolemia with simultaneous gavage of L. johnsonii CCFM1376 for 8 weeks. The biochemical parameters in the serum and liver of hypercholesterolemic mice were measured to assess the alleviating effect of L. johnsonii CCFM1376 on hypercholesterolemia. Bile acid content in the mouse liver, serum, distal ileum contents, and feces was determined using liquid chromatograph mass spectrometer (LC-MS). RNA was extracted from mouse ileum and liver, and the expression levels of relative genes implicated in bile acid metabolism were measured by quantitative real-time PCR (qPCR).

Results: Compared to the model group, the group treated with L. johnsonii CCFM1376 exhibited significantly reduced levels of serum total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C), along with a significant increase in high density lipoproteins cholesterol (HDL-C) level. Moreover, hepatic levels of TC and LDL-C in the CCFM1376 group also decreased significantly. Furthermore, the content and amount of unconjugated bile acids in the hepatic-enteric circulation of the L. johnsonii CCFM1376 group significantly increased, and the total bile acid content in the feces also significantly increased. In the L. johnsonii CCFM1376 group, the relative expression levels of ileal farnesoid X receptor (FXR) and fibroblast growth factor 15 (FGF15) were downregulated, while the relative expression level of CYP7A1 was upregulated.

Conclusion: These results indicated L. johnsonii CCFM1376 improves hypercholesterolemia in mice by regulating the composition of bile acids. This provides a reference for probiotic strategy to regulate cholesterol metabolism.

Keywords

Lactobacillus johnsonii / bile salt hydrolase / bile acids / FXR

References

[1] Civeira F,Cenarro A.A mechanism-based operational definition and classification of hypercholesterolemia.J Clin Lipidol2022;16:813-21

[2] Ference BA,Graham I.Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel.Eur Heart J2017;38:2459-72 PMCID:PMC5837225

[3] Wang G,Xia Y,Ai L.Cholesterol-lowering potentials of Lactobacillus strain overexpression of bile salt hydrolase on high cholesterol diet-induced hypercholesterolemic mice.Food Funct2019;10:1684-95

[4] Wang Y,Xing X.The ameliorative effect of probiotics on diet-induced lipid metabolism disorders: a review.Crit Rev Food Sci Nutr2024;64:3556-72

[5] Jones ML,Martoni CJ.Cholesterol lowering with bile salt hydrolase-active probiotic bacteria, mechanism of action, clinical evidence, and future direction for heart health applications.Expert Opin Biol Ther2013;13:631-42

[6] Schneider KM,Trautwein C.Role of bile acids in the gut-liver axis.J Hepatol2018;68:1083-5

[7] Pushpass RG,Jackson KG.Circulating bile acids as a link between the gut microbiota and cardiovascular health: impact of prebiotics, probiotics and polyphenol-rich foods.Nutr Res Rev2022;35:161-80

[8] Stellaard F.Dynamics of the enterohepatic circulation of bile acids in healthy humans.Am J Physiol Gastrointest Liver Physiol2021;321:G55-66

[9] Joyce SA,Casey PG.Regulation of host weight gain and lipid metabolism by bacterial bile acid modification in the gut.Proc Natl Acad Sci U S A2014;111:7421-6 PMCID:PMC4034235

[10] Li F,Krausz KW.Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity.Nat Commun2013;4:2384 PMCID:PMC6595219

[11] Kliewer SA.Bile acids as hormones: the FXR-FGF15/19 pathway.Dig Dis2015;33:327-31 PMCID:PMC4465534

[12] Chen K,Zhao J.Comparative genomics of Lactobacillus johnsonii reveals extensive intraspecific genetic variation.Food Biosci2023;56:103190

[13] Foley MH,Stewart AK.Bile salt hydrolases shape the bile acid landscape and restrict Clostridioides difficile growth in the murine gut.Nat Microbiol2023;8:611-28 PMCID:PMC10066039

[14] Wang Q,Li X.Lactobacillus reuteri CCFM8631 alleviates hypercholesterolaemia caused by the paigen atherogenic diet by regulating the gut microbiota.Nutrients2022;14:1272 PMCID:PMC8953203

[15] Dang D,Ding M.Limosilactobacillus mucosae FZJTZ26M3 prevents NAFLD in mice through modulation of lipid metabolism and gut microbiota dysbiosis.Food Sci Human Well2024;13:1589-601

[16] Ding M,Chen H.Bifidobacterium longum subsp. infantis regulates Th1/Th2 balance through the JAK-STAT pathway in growing mice.Microbiome Res Rep2024;3:16 PMCID:PMC11149089

[17] Chen X,Stanton C.Dose-response efficacy and mechanisms of Orally administered Bifidobacterium breve CCFM683 on IMQ-induced psoriasis in mice.Nutrients2023;15:1952 PMCID:PMC10143451

[18] Dang D,Chen H,Chen W.In silico, in vitro and in vivo safety assessment of three Limosilactobacillus mucosae strains for probiotic candidates.Food Biosci2024;57:103462

[19] Huang F,Ma X.Theabrownin from Pu-erh tea attenuates hypercholesterolemia via modulation of gut microbiota and bile acid metabolism.Nat Commun2019;10:4971 PMCID:PMC6823360

[20] du Toit M,Dicks LM.Characterisation and selection of probiotic lactobacilli for a preliminary minipig feeding trial and their effect on serum cholesterol levels, faeces pH and faeces moisture content.Int J Food Microbiol1998;40:93-104

[21] Yoon H,Park H,Ji Y.Lactobacillus johnsonii BFE6154 ameliorates diet-induced hypercholesterolemia.Probiotics Antimicrob Proteins2023;15:451-9

[22] Teixeira LD,DeBose-Scarlett E.Lactobacillus johnsonii N6.2 and blueberry phytophenols affect lipidome and gut microbiota composition of rats under high-fat diet.Front Nutr2021;8:757256 PMCID:PMC8551501

[23] Xu J,Cheng S.Lactobacillus johnsonii attenuates liver steatosis and bile acid dysregulation in parenteral nutrition-fed rats.Metabolites2023;13:1043 PMCID:PMC10608838

[24] Zheng X,Zhao A.Bile acid is a significant host factor shaping the gut microbiome of diet-induced obese mice.BMC Biol2017;15:120 PMCID:PMC5731064

[25] Song Z,Zhou X,Li J.Taxonomic identification of bile salt hydrolase-encoding lactobacilli: modulation of the enterohepatic bile acid profile.Imeta2023;2:e128 PMCID:PMC10989828

[26] Zhu H,Zhang W.Cholesterol-lowering effect of bile salt hydrolase from a Lactobacillus johnsonii strain mediated by FXR pathway regulation.Food Funct2022;13:725-36

[27] Zhai Q,Wang C. Lactobacillus plantarum CCFM8661 modulates bile acid enterohepatic circulation and increases lead excretion in mice.Food Funct2019;10:1455-64

[28] Liu Y,Li F.Probiotic Lactobacillus rhamnosus GG prevents liver fibrosis through inhibiting hepatic bile acid synthesis and enhancing bile acid excretion in mice.Hepatology2020;71:2050-66 PMCID:PMC7317518

[29] Liang C,Gong PM.Lactiplantibacillus plantarum H-87 prevents high-fat diet-induced obesity by regulating bile acid metabolism in C57BL/6J mice.Food Funct2021;12:4315-24

[30] Yao L,Ndousse-Fetter S.A selective gut bacterial bile salt hydrolase alters host metabolism.Elife2018;7:e37182 PMCID:PMC6078496

[31] Wahlström A,Marschall HU.Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism.Cell Metab2016;24:41-50

[32] Sayin SI,Felin J.Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist.Cell Metab2013;17:225-35

[33] Degirolamo C,Bovenga F,Moschetta A.Microbiota modification with probiotics induces hepatic bile acid synthesis via downregulation of the Fxr-Fgf15 axis in mice.Cell Rep2014;7:12-8